Fosun Pharma acquired majority stake of Foshan Chanchen Hospital

   Date:2013/12/02     Source:

Fosun Pharmaceutical (Group) Co. acquired 60% stake of Foshan City Chanchen Hospital with RMB 693 million. Based on the agreement, the Chanchen Hospital shall ensure that revenue from 2013-2015 reach RMB 90 million, 108 million and 129 million, respectively.

Fusun pharma maintains its core business pharmaceutical section's investment, in the meantime, also enhance its another strategic segment healthcare service competence. It is also a trend reflected by Gansu Duyiwei, Kangmei Pharma that traditional pharmaceutical companies are turning their attention on the real hospital operations.

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统